Moreover, in-depth investigation of LDLR gene mutations and their pathogenic mechanisms is essential, as it not only sharpens clinicians’ understanding and improves treatment strategies for FH but also significantly contributes to the advancement of disease databases and the elucidation of intricate molecular pathogenic mechanisms. This evidence concerns the gene LDLR and familial hyperaldosteronism.